Abstract
Background: The prevalence of cholelithiasis in developed countries is high and its cause is multifactorial, with a negligible proportion of drug-induced cholelithiasis.
Methods: Relevant studies were identified by PubMed, Google Scholar and Science Direct. Reference lists of retrieved articles were also reviewed. The most relevant and up-to-date information was incorporated.
Results: There is a wide range of drugs that can induce lithiasis. While the risk of developing lithiasis is high with some drugs (ceftriaxone, atazanavir, somatostatin analogues), it is lower or even questionable with others. Some drugs precipitate in the bile and may account for up to 100% of the weight of the stone.
Conclusion: Cholelithiasis can be induced by a wide range of drugs with different mechanisms of action. The aim of the article is to draw attention to this lesser known fact and the need to take into account the risk of developing lithiasis prior to therapy initiation.
Keywords: Cholelithiasis, drugs, ceftriaxone, atazanavir, somatostatin analogues, lithiasis.
Current Reviews in Clinical and Experimental Pharmacology
Title:Drug-induced Cholelithiasis
Volume: 16 Issue: 4
Author(s): Štefan Alušík and Zoltán Paluch*
Affiliation:
- Department of Pharmacology, Second Faculty of Medicine, Charles University, Prague,Czech Republic
Keywords: Cholelithiasis, drugs, ceftriaxone, atazanavir, somatostatin analogues, lithiasis.
Abstract:
Background: The prevalence of cholelithiasis in developed countries is high and its cause is multifactorial, with a negligible proportion of drug-induced cholelithiasis.
Methods: Relevant studies were identified by PubMed, Google Scholar and Science Direct. Reference lists of retrieved articles were also reviewed. The most relevant and up-to-date information was incorporated.
Results: There is a wide range of drugs that can induce lithiasis. While the risk of developing lithiasis is high with some drugs (ceftriaxone, atazanavir, somatostatin analogues), it is lower or even questionable with others. Some drugs precipitate in the bile and may account for up to 100% of the weight of the stone.
Conclusion: Cholelithiasis can be induced by a wide range of drugs with different mechanisms of action. The aim of the article is to draw attention to this lesser known fact and the need to take into account the risk of developing lithiasis prior to therapy initiation.
Export Options
About this article
Cite this article as:
Alušík Štefan and Paluch Zoltán *, Drug-induced Cholelithiasis, Current Reviews in Clinical and Experimental Pharmacology 2021; 16 (4) . https://dx.doi.org/10.2174/1574884715666201217125009
DOI https://dx.doi.org/10.2174/1574884715666201217125009 |
Print ISSN 2772-4328 |
Publisher Name Bentham Science Publisher |
Online ISSN 2772-4336 |
Call for Papers in Thematic Issues
Application of Artificial Intelligence in Assisting Drug Development
We encourage the submission of all types of manuscripts related to the role of artificial intelligence (AI) in enabling rapid and enhanced drug discovery. Our issue focuses on descriptive ways by which AI has led to a better understanding of drug development concerning drug bioavailability, toxicity, cost, and potency.read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (A Significant Step Towards New Altitude)
Current Molecular Medicine Recent Progress on Hydroxyapatite-Based Dense Biomaterials for Load Bearing Bone Substitutes
Recent Patents on Materials Science Metabolomics for Personalized Nutrition Research and Clinical Applications
Current Pharmacogenomics and Personalized Medicine Advances in Zymography Techniques and Patents Regarding Protease Analysis
Recent Patents on Biotechnology The Fallacy of the Longevity Elixir: Negligible Senescence May be Achieved, but Not by Using Something Physical
Current Aging Science CIAPIN1 siRNA Inhibits Proliferation, Migration and Promotes Apoptosis of VSMCs by Regulating Bcl-2 and Bax
Current Neurovascular Research Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Current Drug Targets Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches
CNS & Neurological Disorders - Drug Targets A Review of the Diagnostic Scope of Biomarker Techniques, Genetic Screening and Virtual Scanning
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Genetics and Genomics of Hepatic Acute Phase Reactants: A Mini-Review
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Targeting of Leukocyte Trafficking Across the Blood-Brain Barrier
Inflammation & Allergy - Drug Targets (Discontinued) The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
Current Drug Targets - Infectious Disorders New Analogues of Mycophenolic Acid
Mini-Reviews in Medicinal Chemistry Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?
Current Drug Targets Phage Display Applications for Molecular Imaging
Current Pharmaceutical Biotechnology New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets